SCHEMBL4124653

SCHEMBL4124653

COc1cccc(C(=O)c2cc(C)ccc2NC(=O)C(C)(C)C)c1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.57
TP53 P04637 1/20 0.57
LMNA P02545 3/20 0.47
MAPT P10636 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HTT P42858 1/20 0.47
KCNMA1 Q12791 1/20 0.46
KDM4E B2RXH2 2/20 0.44
RAB9A P51151 4/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 3/20 0.44
JAK2 O60674 1/20 0.44
KCNK3 O14649 2/20 0.43
KCNK9 Q9NPC2 2/20 0.43
ALDH1A1 P00352 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
LPAR1 Q92633 1/20 0.43
NPY2R P49146 1/20 0.42
F10 P00742 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4122118 0.88 TP53 (0.56) GAATP53LMNAMAPTSMN1; SMN2
SCHEMBL4115436 0.82 MEN1 (0.49) GAATP53LMNAMAPTSMN1; SMN2
SCHEMBL4128398 0.81 KCNMA1 (0.50) GAATP53LMNAMAPTSMN1; SMN2
SCHEMBL5520431 0.80 MEN1 (0.49) GAATP53LMNAMAPTSMN1; SMN2
SCHEMBL14146069 0.78 LMNA (0.40) GAATP53LMNARAB9AMEN1
SCHEMBL4128972 0.78 TP53 (0.47) GAATP53LMNAMAPTHTT
SCHEMBL4122136 0.78 LPAR1 (0.48) GAATP53LMNAMAPTKCNMA1
SCHEMBL8140708 0.77 KDM4E (0.57) GAALMNAMAPTKDM4ERAB9A
SCHEMBL4109319 0.77 SMN1; SMN2 (0.48) GAALMNAMAPTSMN1; SMN2KCNMA1
SCHEMBL4124495 0.77 MEN1 (0.47) GAALMNAMAPTSMN1; SMN2KCNMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR GAA 922/4885TP53 4463/4885LMNA 1109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.